Director, Specialty Care Global Pricing and Market Access

Director, Specialty Care Global Pricing & Market Access

Global Pricing and Market Access (GPMA) are key to maximizing the value of our products for patients, healthcare systems and for the company. The vision of the Global Pricing and Market Access team is to be the industry leader in our ability to maximize patient access to life changing vaccines and medicines. To do this, we externally engage payers to fully recognize the value of our assets and internally act as a strategic leader to increase portfolio lifecycle value by delivering innovative solutions. The Director Specialty Care GPMA will leverage clinical understanding, expertise of Evidence Based Medicine, alongside deep global payer knowledge and competitive insights to shape the Pricing & Access strategy, evidence generation, and value communication tools & materials.

Ready to shape the future of healthcare?

Key Responsibilities will be:

• Provide strategic advice and leadership to assigned Specialty Care area (Respiratory, Inflammation and Immunology, Hepatology and Renal) globally with respect to market access and pricing, to develop innovative and competitive Payer Value Propositions and Pricing Strategies for launch and pipeline assets.
• Lead the cross-functional efforts (e.g., Global Market Access & Pricing Team – GMAP / Value and Access Teams – VAT) to deliver close alignment between insights into payer evidence needs, and ensure execution of plans to generate evidence (Integrated Evidence Plan) to support payer value proposition and pricing strategy
• Provide guidance to the Medicines Development Lead (MDL) and Medicines Commercial Lead (MCL) consolidating the payer questions/evidence needs for key markets to inform strategy and tactics
• Input to the evidence generation plan to ensure it will address critical payer questions
• Develop a market access strategy within the brand plans, fit for purpose and aligned to the overall market access strategy
• Assist country affiliates in their reimbursement negotiations by integrating country-specific needs into the pricing and market access strategy, value dossier, training on global materials and pricing/negotiation workshops
• Collaborate effectively with medical and outcomes staff to develop an integrated evidence plan and manage efficient interfaces with key countries
• Represent the market access voice at the MCT and MDT, and ensure that the market access strategy is reflected in key commercial and development decisions

Why you?

Basic qualifications:

• Masters degree in Science/Pharmacy/Medicine/Business/Health Policy/Health Economics discipline
• 10+ years relevant experience acquired at pharmaceutical companies, Payer or Health Technology Assessment agencies, physician associations or relevant consultancy companies in a multi-national context
• 5+ years experience in Pricing and Market Access

Preferred qualifications and skills:

• Strong clinical and disease area knowledge
• Experience in developing and managing market access strategies globally, regionally or in key markets locally, ideally with Specialty Care access experience
• Knowledge of pricing policy & regulations in key markets, ideally with Specialty Care-specific expertise
• Understanding of regulatory agency requirements or policies that govern market approval, and the impact on pricing and reimbursement decisions
• Demonstrated ability to think strategically, manage uncertainty, and make sound global market access and pricing recommendations throughout the lifecycle
• Agility and flexibility to support evolving team and business needs
• Exceptional oral and written communication skills, including the ability to develop and deliver effective presentations to leadership and tailor for different audiences
• Demonstrated ability to effectively lead cross-functional matrix teams and build relationships across functions and geographies

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we're committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.